Skip to content
Explore expert analysis on sports betting using data scienc…

The Zimbabwean Government Rejects ‘One-Sided’ US Health Aid Agreement Because of Data Concerns

Medical aid illustration
The offered American financial assistance would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has turned down a major American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to the United States' demand for confidential biological samples.

This rejection became public after a government memo from December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".

A government representative later stated that the US was requesting health data for scientific study and commercial purposes while was unwilling to guarantee the benefits from future medical innovations.

"We must now begin the challenging and unfortunate task of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for more negotiations to secure a deal suitable to both sides so the country's critical HIV treatment initiative can be sustained.

Wider Implications

This rejection follows a similar situation in Kenya, where a high court blocked a related deal with the US after concerns were raised about the safety of citizens' health data.

After returning to office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost openness and accountability.

As per statements, Sixteen nations in Africa have so far signed similar agreements, representing over $18.3bn of fresh investment.

Details of the Declined Agreement

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this partnership would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no equivalent assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.

"Effectively, our country would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our population should a future disease outbreak arise."

National Interest and Global Health

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems already established through the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.

"This mechanism is intended to guarantee that when a country contributes its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."

These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We encourage continued dialogue with our US partners on how subsequent co-operation might be structured in a way that honours the sovereignty and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but suggested that negotiations must proceed since a large portion of the nation's HIV programmes depended on external financing.

"If technical issues arise, such as those involving data governance or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," it said.

The halted deal underscores the ongoing tensions between receiving much-needed international aid and safeguarding local interests in an ever more data-driven world.

Written by

Michael Barrera

A data scientist specializing in sports analytics with over 8 years of experience in predictive modeling and statistical analysis.

DataBets

Type to search articles.